|
|
MARKETS
RECOMMENDATION:
Aurobindo Pharma (Rs 775.4): Sell
We recommend a sell in the stock of Aurobindo Pharma from a short-term perspective. It is perceptible from the charts of the stock that it has been on a long-term uptrend from November 2008 low of Rs 101.6. It was on an intermediate-term ...
RECOMMENDATION:
Day Trading Guide
The near-term outlook of DLF is bearish. We recommend a sell. Utilise dips to buy ICICI Bank with tight stop-loss at Rs 756. Avoid trading in Infosys as the stance is cautious for ...
FOREIGN INSTITUTIONAL INVESTORS:
Sensex dives on FII selling
Mumbai, Oct. 29 The BSE Sensex dived 230 points on Thursday as foreign institutional investors continued their selling amid negative global cues and rising inflation concerns. The benchmark index closed at 16,052.70. The broader Nifty closed ...
STOCKS:
Liquidity squeeze fear hits realty
Recent recovery not backed by real demand. Kolkata, Oct. 29 Real estate stocks are seeing marked hammering. On Thursday, BSE realty index lost 6.4 per cent on significant sell off. The index, which hit its year-high October 21, has declined by ...
PUBLIC OFFER:
Govt approves REC’s follow-on public offer
New Delhi, Oct. 29 The Centre approved Rural Electrification Corporation’s proposal for a follow-on-public offer (FPO) on Thursday. The issue will constitute 20 per cent of the existing paid-up capital of the company — fresh equity ...
Columnists:
•
Harish Bijoor
•
Ramanujam Sridhar
•
S Ramesh Kumar
•
Radhika Chada
Comments & Letters to the Editor to: bleditor@thehindu.co.in
Subscribe to: Business Line
|
|
RSS Feeds